XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' (DEFICIT) EQUITY - USD ($)
Ordinary shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2022 $ 200 $ 27,028 $ (11,228) $ 16,000
Balance at the beginning (in shares) at Dec. 31, 2022 2,003,000      
Increase (decrease) in Stockholders' (deficit) equity        
Sale of 545,000 private units $ 55 5,449,945   $ 5,450,000
Sale of 545,000 private units (in shares) 545,000     545,000
Fair value of public warrants at issuance   1,104,000   $ 1,104,000
Fair value of representative shares   1,185,493   1,185,493
Fair value of rights included in public units   3,305,100   3,305,100
Fair value of representative warrants   12,075   12,075
Allocated value of transaction costs   (354,297)   (354,297)
Accretion for ordinary shares to redemption amount   (10,072,026)   (10,072,026)
Net (loss) income     251,313 251,313
Balance at the end at Mar. 31, 2023 $ 255 657,318 240,085 897,658
Balance at the end (in shares) at Mar. 31, 2023 2,548,000      
Balance at the beginning at Dec. 31, 2022 $ 200 27,028 (11,228) 16,000
Balance at the beginning (in shares) at Dec. 31, 2022 2,003,000      
Increase (decrease) in Stockholders' (deficit) equity        
Accretion for ordinary shares to redemption amount       (10,653,731)
Net (loss) income       688,667
Balance at the end at Jun. 30, 2023 $ 255 75,613 677,439 753,307
Balance at the end (in shares) at Jun. 30, 2023 2,548,000      
Balance at the beginning at Dec. 31, 2022 $ 200 27,028 (11,228) 16,000
Balance at the beginning (in shares) at Dec. 31, 2022 2,003,000      
Increase (decrease) in Stockholders' (deficit) equity        
Accretion for ordinary shares to redemption amount       (12,089,247)
Balance at the end at Dec. 31, 2023 $ 255   (66,400) (66,145)
Balance at the end (in shares) at Dec. 31, 2023 2,548,000      
Balance at the beginning at Mar. 31, 2023 $ 255 657,318 240,085 897,658
Balance at the beginning (in shares) at Mar. 31, 2023 2,548,000      
Increase (decrease) in Stockholders' (deficit) equity        
Accretion for ordinary shares to redemption amount   (581,705)   (581,705)
Net (loss) income     437,354 437,354
Balance at the end at Jun. 30, 2023 $ 255 $ 75,613 677,439 753,307
Balance at the end (in shares) at Jun. 30, 2023 2,548,000      
Balance at the beginning at Dec. 31, 2023 $ 255   (66,400) (66,145)
Balance at the beginning (in shares) at Dec. 31, 2023 2,548,000      
Increase (decrease) in Stockholders' (deficit) equity        
Accretion for ordinary shares to redemption amount     (570,793) (570,793)
Net (loss) income     32,539 32,539
Balance at the end at Mar. 31, 2024 $ 255   (604,654) (604,399)
Balance at the end (in shares) at Mar. 31, 2024 2,548,000      
Balance at the beginning at Dec. 31, 2023 $ 255   (66,400) (66,145)
Balance at the beginning (in shares) at Dec. 31, 2023 2,548,000      
Increase (decrease) in Stockholders' (deficit) equity        
Accretion for ordinary shares to redemption amount       (1,196,096)
Net (loss) income       (95,393)
Balance at the end at Jun. 30, 2024 $ 255   (1,357,889) (1,357,634)
Balance at the end (in shares) at Jun. 30, 2024 2,548,000      
Balance at the beginning at Mar. 31, 2024 $ 255   (604,654) (604,399)
Balance at the beginning (in shares) at Mar. 31, 2024 2,548,000      
Increase (decrease) in Stockholders' (deficit) equity        
Accretion for ordinary shares to redemption amount     (625,303) (625,303)
Net (loss) income     (127,932) (127,932)
Balance at the end at Jun. 30, 2024 $ 255   $ (1,357,889) $ (1,357,634)
Balance at the end (in shares) at Jun. 30, 2024 2,548,000